Plasma Growth Hormone in Patients with Chromosomal Anomalies
Overview
Authors
Affiliations
GHRH-GH-IGF1 axis in pediatric Down syndrome: A systematic review and mini meta-analysis.
Shaki D, Hershkovitz E, Tamam S, Bollotin A, David O, Yalovitsky G Front Pediatr. 2023; 11:1132296.
PMID: 36911030 PMC: 9992742. DOI: 10.3389/fped.2023.1132296.
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome.
Araya P, Kinning K, Coughlan C, Smith K, Granrath R, Enriquez-Estrada B Cell Rep. 2022; 41(13):111883.
PMID: 36577365 PMC: 9876612. DOI: 10.1016/j.celrep.2022.111883.
Anneren G, Tuvemo T, Carlsson-Skwirut C, Lonnerholm T, Bang P, Sara V Arch Dis Child. 1999; 80(4):334-8.
PMID: 10086938 PMC: 1717881. DOI: 10.1136/adc.80.4.334.
Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome.
Barreca A, Rasore Quartino A, Acutis M, Ponzani P, Damonte G, Miani E J Endocrinol Invest. 1994; 17(6):431-6.
PMID: 7930388 DOI: 10.1007/BF03347731.
Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome.
Butenandt O Klin Wochenschr. 1980; 58(2):99-101.
PMID: 7366123 DOI: 10.1007/BF01477194.